An improved plasmid DNA expression vector for direct injection into skeletal muscle

Human Gene Therapy

Volumn 7, Issue 10, 1996, Pages 1205-1217

  Hartikka, Jukka ^a   Sawdey, Michael ^a   Cornefert Jensen, Francine ^a   Margalith, Michal ^a   Barnhart, Kerry ^a   Nolasco, Michelle ^a   Vahlsing, H Lee ^a   Meek, Jennifer ^a   Marquet, Magda ^a   Hobart, Peter ^a   Norman, Jon ^a   Manthorpe, Marston ^a  

^a VICAL INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; PLASMID DNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DNA TRANSFER; ENHANCER REGION; EXPRESSION VECTOR; FEMALE; GENE THERAPY; INTRAMUSCULAR DRUG ADMINISTRATION; INTRON; MOUSE; NONHUMAN; PROMOTER REGION; SKELETAL MUSCLE;

ANIMALIA; MURINAE;

EID: 19144367904     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.10-1205     Document Type: Article

References (65)

1. ACSADI, G. DICKSON, G., LOVE, D.R., JANI, A., WALSH, F.S., GURUSINGHE, A., WOLFF, J.A., and DAVIES, K.E. (1991). Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs [see comments]. Nature 352, 815-818.
2. AXELROD, J.H., READ, M.S., BRINKHOUS, K.M., and VERMA, I.M. (1990). Phenotypic correction of factor IX deficiency in skin fibroblasts of hemophilic dogs. Proc. Natl. Acad. Sci. USA 87, 5173-5177.
3. BARRY, M.A., LAI, W.C., and JOHNSTON, S.A. (1995). Protection against mycoplasma infection using expression library immunization. Nature 377, 632-635.
4. BIRNSTIEL, M.L., BUSSLINGER, M., and STRUB, K. (1985). Transcription termination and 3′ processing: The end is in site! Cell 4, 349-359.
5. BOSHART, M., WEBER, F., JAHN, G., DORSCH-HASLER, K., FLECKENSTEIN, B., and SCHAFFNER, W. (1985). A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41, 521-530.
6. CHAPMAN, B.S., THAYER, R.M., VINCENT, K.A., and HAIGWOOD, N.L. (1991). Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells. Nucleic Acids Res. 19, 3979-3986.
7. CHOI, T., HUANG, M., GORMAN, C., and JAENISCH, R. (1991). A generic intron increases gene expression in transgenic mice. Mol. Cell. Biol. 11, 3070-3074.
8. CONRY, R.M., LOBUGLIO, A.F., LOECHEL, F., MOORE, S.E., SUMEREL, L.A., BARLOW D.L., and CURIEL, D.T. (1995). A carcinoembryonic antigen polynucleotide vaccine has in vivo antitumor activity. Gene Ther. 2, 59-65.
9. COX, G.J., ZAMB, T.J., and BABIUK, L.A. (1993). Bovine herpesvirus 1: Immune responses in mice and cattle injected with plasmid DNA. J. Virol. 67, 5664-5667.
10. DAI, Y., ROMAN, M., NAVIAUX, R.K., and VERMA, I.M. (1992). Gene therapy via primary myoblasts: Long-term expression of factor IX protein following transplantation in vivo. Proc. Natl. Acad. Sci. USA 89, 10892-10895.
11. DAVIS, H.L., and JASMIN, B.J. (1993). Direct gene transfer into mouse diaphragm. FEBS Lett. 383, 146-150.
12. DAVIS, H.L., DEMENEIX, B.A., QUANTIN, B., COULOMBE, J., and WHALEN, R.G. (1993). Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle. Hum. Gene Ther. 4, 733-740.
13. DE WET, J.R., WOOD, K.V., DELUCA, M., HELINSKI, D.R., and SUBRAMANI, S. (1987). Firefly luciferase gene: structure and expression in mammalian cells. Mol. Cell. Biol. 7, 725-737.
14. DUBIN, R.A., GOPAL-SRIVASTAVA, R., WAWROUSEK, E.F., and PIATIGORSKY, J. (1991). Expression of the murine alpha B-crystallin gene in lens and skeletal muscle: Identification of a muscle-preferred enhancer. Mol. Cell. Biol. 11, 4340-4349.
15. EVANS, M.J., and SCARPULLA, R.C. (1989). Introns in the 3′ untranslated region can inhibit chimeric CAT and beta-galactosidase expression. Gene 84, 135-142.
16. FAZIO, V.M., FAZIO, S., RINALDI, M., CATANI, M.V., ZOTTI, S., CIAFRE, S.A., SERIPA, D., RICCI, and FARACE, M.G. (1994). Accumulation of human apolipoprotein-E in rat plasma after in vivo intramuscular injection of plasmid DNA. Biochem. Biophys. Res. Commun. 200, 298-305.
17. FIERS, W., CONTRERAS, R., HAEGEMANN, G., ROGIERS, R., VAN DE VOORDE, A., VAN HEUVERSWYN, H., VAN HERREWEGHE, J., VOLCKAERT, G., and YSEBAERT, M. (1978). Complete nucleotide sequence of SV40 DNA. Nature 273, 113-120.
18. GEISSLER, E.K., WANG, J., FECHNER, JR., J.H., BURLINGHAM, W.J., and KNECHTLE, S.J. (1994). Immunity to MHC class I antigen after direct DNA transfer into skeletal muscle. J. Immunol. 152, 413-421.
19. GHAZAL, P., LUBON, H., FLECKENSTEIN, B., and HENNINGHAUSEN, L. (1987). Binding of transcription factors and creation of a large nucleoprotein complex on the human cytomegalovirus enhancer. Proc. Natl. Acad. Sci. USA 84, 3658-3662.
20. GIL A., and PROUDFOOT, N.J. (1987). Position-dependent sequence elements downstream of AAUAAA are required for efficient rabbit β-globin 3′ end formation. Cell 49, 399-406.
21. GOODWIN, E.C., and ROTTMAN, F.M. (1992). The 3′-flanking sequence of the bovine growth hormone gene contains novel elements required for efficient and accurate polyadenylation. J. Biol. Chem. 267, 16330-16334.
22. GOULD, S.J., KELLER, G.A., HOSKEN, N., WILKINSON, J., and SUBRAMANI, S. (1989). A conserved tripeptide sorts proteins to peroxisomes. J. Cell Biol. 108, 1657-1664.
23. HANSEN, E., FERNANDES, K., GOLDSPINK, G., BUTTERWORTH, P., UMEDA, P.K., and CHANG, K.C. (1991). Strong expression of foreign genes following direct injection into fish muscle. FEBS Lett. 290, 73-76.
24. HARMS, J., and SPLITTER, G. (1995). Interferon-γ inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter. Hum. Gene Ther. 6, 1291-1297.
25. HICKMAN, M.A., MALONE, R.W., LEHMANN-BRUINSMA, K., SIH, T.R., KNOELL, D., SZOKA, F.C., WALZEM, R., CARLSON, D.M., and POWELL, J.S. (1994). Gene expression following direct injection of DNA into liver. Hum. Gene Ther. 5, 1477-1483.
26. HOHLFELD, R., and ENGEL, A.G. (1984). The immunobiology of muscle. Immunol. Today 15, 269-274.
27. HORN, N., MEEK, J., BUDAHAZI, G., and MARQUET, M. (1995). Cancer gene therapy using plasmid DNA: Purification of DNA for human clinical trials. Hum. Gene Ther. 6, 565-573.
28. HUANG, M.T.F., and GORMAN, C.M. (1990a). The simian virus small-t intron, present in many common expression vectors, leads to aberrant splicing. Mol. Cell. Biol. 10, 1805-1810.
29. HUANG, M.T.F., and GORMAN, C.M. (1990b). Intervening sequences increase efficiency of RNA 3′ processing and accumulation of cytoplasmic RNA. Nucleic Acids Res. 18, 937-946.
30. JIAO, S., WILLIAMS, P., BERG, R.K., HODGEMAN, B.A., LIU, L., REPETTO, G., and WOLFF, J.A. (1992). Direct gene transfer into nonhuman primate myofibers in vivo. Hum. Gene Ther. 3, 21-33.
31. KRIEG, A.M., YI, A.-K., MATSON, S., WALDSCHMIDT, T.J., BISHOP, G.A., TEASDALE, R., KORETZKY, G.A., and KLINMAN, D.M. (1995). CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 546-549.
32. LEW, D., PARKER, S.E., LATIMER, T., ABAI, A., KUWAHARA-RUNDELL, A., DOH, S.G., YANG, Z., LAFACE, D., GROMKOWSKI, S.H., NABEL, G.J., MANTHORPE, M., and NORMAN, J. (1995). Cancer gene therapy using plasmid DNA: Pharmacokinetic study of DNA following injection into mice. Hum. Gene Ther. 6, 553-564.
33. LEVITT, N., BRIGGS, D., GIL, A., and PROUDFOOT, N.J. (1989). Definition of an efficient synthetic poly(A) site. Genes & Dev. 3, 1019-1025.
34. LIANG, X., HARTIKKA, J., SUKHU, L., MANTHORPE, M., and HOBART, P. (1996). Novel, high expressing, and antibiotic controlled plasmid vectors for use in gene therapy. Gene Ther. 3, 350-356.
35. LIN, H., PARMACEK, M.S., MORLE, G., BOLLING, S., and LEIDEN, J.M. (1990). Expression of recombinant genes in myocardium in vivo after direct injection of DNA. Circulation 82, 2217-2221.
36. MA, J.X., YANG, Z., CHAO, J., CHAO, L. (1995). Intramuscular delivery of rat kallikrein-binding protein gene reverses hypotension in transgenic mice expressing human tissue kallikrein. J. Biol. Chem. 270, 451-155.
37. MANTEGAZZA, R., and BERNASCONI, P. (1994). Cellular aspects of myositis. Curr. Opin. Rheumatol. 6, 568-574.
38. MANTHORPE, M., CORNEFERT-JENSEN, F., HARTIKKA, J., FELGNER, J., RUNDELL, A., MARGALTH, M., and DWARKI, V.J. (1993). Gene therapy by intramuscular injection of plasmid DNA: Studies on firefly luciferase gene expression in mice. Hum. Gene Ther. 4, 419-421.
39. MARGALITH, M., KHATIBI, S., and HOBART, P. (1995). VCL-1102: A plasmid DNA vector to effect high levels of IL-2 expression in vivo. J. Cell. Biochem. 21A, 425.
40. McLAUCHLAN, J., GAFFNEY, D., WHITTON, J.L., and CLEMENTS, J.B. (1985). The consensus sequence YGTGTTYY located downstream from the AATAAA signal is required for efficient formation of mRNA 3′ termini. Nucl. Acids Res. 13, 1347-1368.
41. MECKERT, P.C., HONTEBEYRIE-JOSKOWICZ, M., CHAMBO, J., LEVIN, M., and LAGUENS, R.P. (1991). Trypanosoma cruzi: Aberrant expression of class II major histocompatibility complex molecules in skeletal and heart muscle cells of chronically infected mice. Exp. Parasitol. 72, 8-14.
42. MIKKELSEN, T.R., CHAPMAN, B., DIN, N., INGERSLEV, J., KRISTENSEN, P., POULSEN, K., and HJORTH, J.P. (1992). Expression of a cytomegalovirus IE-1-factor VIII cDNA hybrid gene in transgenic mice. Transgen. Res. 1, 164-169.
43. MONTGOMERY, D.L., SHIVER, J.W., LEANDER, K.R., PERRY, H.C., FRIEDMAN, A., MARTINEZ, D., ULMER, J.B., DONNELLY, J.J., and LIU, M.A. (1993). Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors. DNA Cell Biol. 12, 777-783.
44. PARDOLL, D., and BECKERLEG, A.M. (1995). Exposing the immunology of naked DNA vaccines. Immunity 3, 165-169.
45. PARKER, S.E., VAHLSING, L.H., SERFILIPPI, L.M., FRANKLIN, C.L., DOH, S.G., GROMKOWSKI, S.H., LEW, D., MANTHORPE, M., and NORMAN, J. (1995). Cancer gene therapy using plasmid DNA: Safety evaluation in rodents and nonhuman primates. Hum. Gene Ther. 6, 575-590.
46. PARKER, S.E., KHATIBI, S., MARGALITH, M., ANDERSON, D., YANKAUCKAS, M., GROMKOWSKI, S.H., LATIMER, T., LEW, D., MARQUET, M., MANTHORPE, M., HOBART, P., HERSH, E., STOPECK, A.T., and NORMAN, J. (1996). Plasmid DNA gene therapy: Studies with the human interleukin-2 gene in tumor cells in vitro and in the murine b16 melanoma model in vivo. Cancer Gene Ther. (in press).
47. PEREZ-MARTIN, J., ROJO, F., and DE LORENZO, V. (1994). Promoters responsive to DNA bending: a common theme in prokaryotic gene expression. Microbiol. Rev. 58, 268-290.
48. PROUDFOOT, N.J. (1989). How RNA polymerase II terminates transcription in higher eukaryotes. Trends Biochem. Sci. 14, 105-110.
49. PROUDFOOT, N.J. (1991). High altitude termination. Regulation of transcription elongation and termination: a Keystone symposium, Keystone CO, USA, April 19-25, 1991. New Biol. 3, 851-854.
50. PROUDFOOT, N.J., and WHITELAW, E. (1988). In Frontiers in Molecular Biology. D.B. Hames and D. Glover, eds. (IRL press, Oxford) pp. 97-129.
51. RAZ, E., WATANABE, A., BAIRD, S.M., EISENBERG, R.A., PARR, T.B., LOTZ, M., KIPPS, T.J., and CARSON, D.A. (1993). Systemic immunological effects of cytokine genes injected into skeletal muscle. Proc. Natl. Acad. Sci. USA 90, 4523-4527.
52. SAHENK, Z., SEHARASEYON, J., MENDELL, J.R., and BURGHES, A.H. (1993). Gene delivery to spinal motor neurons. Brain Res. 606, 126-129.
53. SAMBROOK, J., FRITSCH, E.F., and MANIATIS, T. (1989). Molecular Cloning: A Laboratory Manual, 2nd ed. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY).
54. SEDEGAH, M., HEDSTROM, R., HOBART, P., and HOFFMAN, S.L. (1994). Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc. Natl. Acad. Sci. USA 91, 9866-9870.
55. SPOONER, R.A., DEONARAIN, M.P., and EPENETOS, A.A. (1995). DNA vaccination for cancer treatment. Gene Ther. 2, 173-80.
56. SVENSSON, E.C., BLACK, TRIPATHY, S.K., MARGALITH, M., HOBART, P.M., and LEIDEN, J.M. (1996). Long-term expression of physiologic levels of erythropoietin in mice following a single intramuscular injection of plasmid DNA. In Keystone Symposia on Molecular and Cellular Biology: The Molecular Biology of the Cardiovascular System. J. Leiden, ed. (Frederic Printing, Denver, CO) p. 57.
57. THOMSEN, D.R., STENBERG, R.M., GOINS, W.F., and STINSKI, M.F. (1984). Promoter-regulatory region of the major immediate early gene of human cytomegalovirus. Proc. Natl. Acad. Sci. USA 81, 659-663.
58. TOMITA, N., HIGAKI, J., KANEDA, Y., and OGIHARA, T. (1992) [Direct in vivo gene introduction into rat kidney]. Nippon Rinsho. 50, 2874-2878.
59. ULMER, J.B., DONNELLY, J.J., PARKER, S.E., RHODES, G.H., FELGNER, P.L., DWARKI, V.J., GROMKOWSKI, S.H., DECK, R.R., DEWITT, C.M., FRIEDMAN, A., and LIU, M. (1992) Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745-1749.
60. WOLFF, J.A., MALONE, R.W., WILLIAMS, P., CHONG, W., ACSADI, G., JANI, A., and FELGNER, P.L. (1990). Direct gene transfer into mouse muscle in vivo. Science 247, 1465-1468.
61. WOLFF, J.A., DOWTY, M.E., JIAO, S., REPETTO, G., BERG, R.K., LUDTKE, J.J., WILLIAMS, P., and SLAUTTERBACK, D.B. (1992). Expression of naked plasmids by cultured myotubes and entry of plasmids into T tubules and caveolae of mammalian skeletal muscle. J. Cell Sci. 103, 1249-1259.
62. XIONG, W., CHAO, J., and CHAO, L. (1995). Muscle delivery of human kallikrein gene reduces blood pressure in hypertensive rats. Hypertension 25, 715-719.
63. XU, D., and LIEW, F.Y. (1995). Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein, gp63, of L. major. Immunology 84, 173-176.
64. YANG, Y., NUNES, F.A., BERENSCI, E.E., FURTH, GONCZOL, E., and WILSON, J.M. (1994). Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91, 4407-4411.
65. YANG, W., WAINE, G.J., and McMANUS, D.P. (1995). Antibodies to Shistosoma japonicum (Asian bloodfluke) paramyosin induced by nucleic acid vaccination. Biochem. Biophys. Commun. 212, 1029-1039.